Prof. Dr. med. Joachim Schofer

 

 

Rieß

 

Prof. Dr. med. J. Schofer
Leitender Arzt
Department perkutane Behandlung von Herzklappenerkrankungen im Albertinen-Krankenhaus

 

 

 

 

1978 Medizinisches Staatsexamen an der Philips-Universität Marburg
1978 –1980 Assistenzarzt in der Abteilung für Pharmakologie (Direktor: Prof. Dr. D. Palm) der Goethe-Universität zu Frankfurt
1980 Promotion zum Dr. med. an der Goethe-Universität zu Frankfurt
1980 – 1986 Assistenzarzt in der I. Medizinischen Klinik (Direktor: Prof. Dr. H. Greten) und der Abteilung für Kardiologie (Direktor: Prof. Dr. W. Bleifeld) des Universitätskrankenhauses Eppendorf (UKE) in Hamburg
1986 – 1990 Oberarzt in der Abteilung für Kardiologie des UKE
1986 Facharzt für Innere Medizin und Kardiologie
1987 Habilitation, Thema: „Frühzeitige Erfolgsbeurteilung der Thrombolysetherapie beim akuten Myokardinfarkt mit szintigraphischen Methoden.“
1987 Venia legendi
1992 Professor für Innere Medizin
1990 Leiter (zusammen mit Prof. Dr. med. D. Mathey) der Kardiologischen Gemeinschaftspraxis Prof. Mathey, Prof. Schofer & Partner in Hamburg
May, 2005 Co-Founder of the “Universitäres Herz- und Gefäßzentrum Hamburg GmbH“ (Hamburg University Cardiovascular Center) und des Medizinischen Versorgungszentrums Prof. Mathey, Prof. Schofer in Hamburg und
seit 1-2014 Leiter des Departments für die perkutane Behandlung von Herzklappenerkrankungen im Albertinen-Herz und Gefäßzentrum Hamburg

 

 

 

 

Literatur 2016 - 2017
1. Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge Mit-raClip Technique. Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, Rudolph V, Friedrichs K, Maisano F, Taramasso M, Fam N, Bianchi G, Bedogni F, Denti P, Alfieri O, Latib A, Colombo A, Hammerstingl C, Schueler R. Circulation. 2017 May 9;135(19):1802-1814.

 

2. Independent Modular Filter for Embolic Protection in Carotid Stenting.Scheinert D, Rei-mers B, Cremonesi A, Schmidt A, Sievert H, Rohde S, Schofer J, Mudra HG, Bosiers M, Zeller T, Pacchioni A, Rosenschein U; WISE (Wirion Study Europe) Pivotal Trial Investigators. Circ Cardiovasc Interv. 2017 Mar;10(3).

 

3. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. Lansky AJ, Messé SR, Brickman AM, Dwyer M, van der Worp HB, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Moy CS, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A.J Am Coll Cardiol. 2017 Feb 14;69(6):679-691

 

4. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. Lansky AJ, Messé SR, Brickman AM, Dwyer M, Bart van der Worp H, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Scala Moy C, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A. Eur Heart J. 2017 Feb 7.

 

5. Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair. Yzeiraj E, Bijuklic K, Tiburtius C, Witt J, Krause K, Steude J, Hansen L, Rieß FC, Schofer J. EuroIntervention. 2017 Feb 3;12(15):e1817-e1824.

 

6. Bipolar radiofrequency renal denervation with the Vessix catheter in patients with re-sistant hypertension: 2-year results from the REDUCE-HTN trial.Sievert H, Schofer J, Ormis-ton J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J. J Hum Hypertens. 2017 May;31(5):366-368.

 

7. Long-term major adverse cardiac and cerebrovascular events (MACCE) rate : Comparison of retrograde and antegrade recanalization of chronic total coronary occlusions. Bijuklic K, Schwencke C, Schofer J. Wien Klin Wochenschr. 2017 Apr;129(7-8):243-250.

 

8. A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis. Naber CK, Pyxaras SA, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, Den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck KH, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner D, Latib A, De Marco F, Kische S. EuroIntervention. 2016 Dec 10;12(11):e1413-e1419.

 

9. Impact of cardiac comorbidities on early and 1-year outcome after percutaneous mitral valve interventions: data from the German transcatheter mitral valve interventions (TRAMI) registry. Schwencke C, Bijuklic K, Ouarrak T, Lubos E, Schillinger W, Plicht B, Eggebrecht H, Baldus S, Schymik G, Boekstegers P, Hoffmann R, Senges J, Schofer J. Clin Res Cardiol. 2017 Apr;106(4):249-258.

 

10. On-Pump versus Off-Pump Complete Arterial Revascularization Using Bilateral Internal Mammary Arteries and the T-Graft Technique: Clinical and Angiographic Results for 3,445 Patients in 13 Years of Follow-Up. Riess FC, Heller S, Cramer E, Awwad N, Amin W, Hansen L, Lehmann C, Schofer J, Stripling J, Winkel S, Kremer P. Cardiology. 2017;136(3):170-179.

 

11. Transcatheter interventions for tricuspid regurgitation: Trialign and Mitralign.Schofer J. EuroIntervention. 2016 Sep 18;12(Y):Y119-20.

 

12. Transcatheter Therapies for Treating Tricuspid Regurgitation. Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R, Vahanian A. J Am Coll Cardiol. 2016 Apr 19;67(15):1829-45.

 

13. All over for valve surgery for intermediate-risk patients? Schofer J. Lancet. 2016 May 28;387(10034):2170-1

 

14. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. Abizaid A, Costa RA, Schofer J, Ormiston J, Maeng M, Witzenbichler B, Botelho RV, Costa JR Jr, Chamié D, Abizaid AS, Castro JP, Morrison L, Toyloy S, Bhat V, Yan J, Verheye S. JACC Cardiovasc Interv. 2016 Mar 28;9(6):565-74

 

15. Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System. Schofer J, Tiburtius C, Hammerstingl C, Dickhaut PO, Witt J, Hansen L, Riess FC, Bijuklic K. J Am Coll Cardiol. 2016 Feb 23;67(7):889-90.

 

16. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study. Lefèvre T, Colombo A, Tchétché D, Latib A, Klugmann S, Fajadet J, De Marco F, Maisano F, Bruschi G, Bijuklic K, Nava S, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Schofer J. JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75.

 

17. Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial. Costa RA, Abizaid A, Mehran R, Schofer J, Schuler GC, Hauptmann KE, Magalhães MA, Parise H, Grube E; BioFreedom FIM Clinical Trial Investigators. JACC Cardiovasc Interv. 2016 Jan 11;9(1):51-64.

 

18. Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation. Schofer J, Nietlispach F, Bijuklic K, Colombo A, Gatto F, De Marco F, Mangieri A, Hansen L, Bruschi G, Ruparelia N, Rieß FC, Maisano F, Latib A. JACC Cardiovasc Interv. 2015 Dec 21;8(14):1842-9.

 

19. First-in-man transcatheter mitral valve-in-ring implantation with a repositionable and retrievable aortic valve prosthesis. Latib A, Ruparelia N, Bijuklic K, De Marco F, Gatto F, Hansen L, Ozbek C, Greilach P, Bruschi G, Rieß FC, Alfieri O, Colombo A, Schofer J. EuroIntervention. 2016 Feb;11(10):1148-52.

 

20. Recanalization of chronic total coronary occlusions--high success rate despite a restrictive use of the retrograde approach. Bijuklic K, Schwencke C, Schofer J. Catheter Cardiovasc Interv. 2016 Apr;87(5):E183-91.

 

21. Increased Risk of Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty. Bijuklic K, Haselbach T, Witt J, Krause K, Hansen L, Gehrckens R, Rieß FC, Schofer J. JACC Cardiovasc Interv. 2015 Oct;8(12):1608-13.

 

22. Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function. Schueler R, Nickenig G, May AE, Schillinger W, Bekeredjian R, Ouarrak T, Schofer J, Hehrlein C, Sievert H, Boekstegers P, Lubos E, Hoffmann R, Baldus S, Senges J, Hammerstingl C. EuroIntervention. 2016 Jul 20;12(4):508-14.

 

23. A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent: The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). Schofer J, Musiałek P, Bijuklic K, Kolvenbach R, Trystula M, Siudak Z, Sievert H. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1229-34.

 

24. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC). J Am Coll Cardiol. 2015 Jul 21;66(3):278-307.

 

25. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium. Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC). Eur Heart J. 2015 Aug 1;36(29):1851-77.

 

26. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, Abrams K, Forrest JK, Cleman M, Reinöhl J, Cuisset T, Blackman D, Bolotin G, Spitzer S, Kappert U, Gilard M, Modine T, Hildick-Smith D, Haude M, Margolis P, Brickman AM, Voros S, Baumbach A. Eur Heart J. 2015 Aug 14;36(31):2070-2078.

 

27. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Maisano F, Alfieri O, Banai S, Buchbinder M, Colombo A, Falk V, Feldman T, Franzen O, Herrmann H, Kar S, Kuck KH, Lutter G, Mack M, Nickenig G, Piazza N, Reisman M, Ruiz CE, Schofer J, Søndergaard L, Stone GW, Taramasso M, Thomas M, Vahanian A, Webb J, Windecker S, Leon MB. Eur Heart J. 2015 Jul 7;36(26):1651-9.

 

28. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. J Am Coll Cardiol. 2015 Mar 31;65(12):1190-5.

 

29. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study. Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M. EuroIntervention. 2015 Feb;10(10):1213-20.

 

30. Clinical outcome of critically ill, not fully recompensated, patients undergoing MitraClip therapy. Rudolph V, Huntgeburth M, von Bardeleben RS, Boekstegers P, Lubos E, Schillinger W, Ouarrak T, Eggebrecht H, Butter C, Plicht B, May A, Franzen O, Schofer J, Senges J, Baldus S. Eur J Heart Fail. 2014 Nov;16(11):1223-9.

 

31. Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation. Bijuklic K, Hansen L, Witt J, Schofer J. Clin Res Cardiol. 2015 Jan;104(1):92-3.

 

32. Svelte integrated delivery system performance examined through diagnostic catheter delivery: the SPEED registry. Khattab AA, Nijhoff F, Schofer J, Berland J, Meier B, Nietlispach F, Agostoni P, Brucks S, Stella P. Catheter Cardiovasc Interv. 2015 Jan 1;85(1)

 

33. Who comes off best with closed chest? Aortic valve replacement in patients with high surgical risk. Schofer J. J Am Coll Cardiol. 2014 Mar 25;63(11):1110-1. doi: 10.1016/j.jacc.2013.10.059.

 

34. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. Schofer J, Colombo A, Klugmann S, Fajadet J, DeMarco F, Tchétché D, Maisano F, Bruschi G, Latib A, Bijuklic K, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Lefevre T. J Am Coll Cardiol. 2014 Mar 4;63(8):763-8.

 

 

Hamburg, June, 2017

 

Chefärzte

 

Rieß

 

Prof. Dr. med. Friedrich-Christian Rieß
Chairman des Herz- und Gefäßzentrums 
Chefarzt der Herzchirurgie
Tel. 040 55 88-2445
E-Mail

Lebenslauf | Publikationen

Kremer

 

Prof. Dr. Karsten Sydow
Chefarzt der Kardiologie
Tel. 040 55 88-2237
E-Mail

 

 

Kock

 

Dr. med. Lars Kock
Chefarzt der Klinik für

Gefäß- und endovaskuläre Chirurgie
Tel. 040 55 88-2857
E-Mail

 

 

Kormann

 

Dr. med. Christine L├Âwer
Leitende Ärztin
Department f├╝r Kardioan├Ąsthesie
Tel. 040 55 88-2445
E-Mail

 

 

Schofer

 

Dr. med. Matthias Gasthaus
Chefarzt der Kardiologie

Amalie Sieveking-

Krankenhaus
Tel. 040 6 44 11-233
E-Mail

 

Schofer

 

Prof. Dr. med. J. Schofer
Leitender Arzt
Department perkutane Behandlung von Herzklappenerkrankungen im Albertinen-Krankenhaus
Tel. 040 55 88-2442 /-2453 /-2445
E-Mail

Lebenslauf und Publikationen

 

Schofer

 

Prof. Dr. med. Herbert Nägele
Leitender Arzt
Department für Herzinsuffizienz und Devicetherapie im Albertinen-Krankenhaus
Tel. 040 55 88-2847
E-Mail

 

Zerm

 

Dr. Thomas Zerm
Leitender Arzt

Department für Elektrophysiologie
Albertinen Herz- und Gefäßzentrum
Tel. 040 55 88-2864
E-Mail

 

 

 

 

 

 

 

 

focus

 

 

Workshop komplett arterielle Revaskularisation

 

Jubiläum

 

Matthias Scheller, Vorstandsvorsitzender des Albertinen-Diakoniewerkes e.V., gratuliert dem Gründervater des Albertinen Herz- und Gefäßzentrums, Prof. W. F├╝llbrandt und den M├Ąnnern der ersten Stunde anlässlich des Jubiläums "25 Jahre Herzmedizin am Albertinen-Krankenhaus"

 

Von links: M. Scheller, Prof. W. Füllbrandt, Prof. F.-C. Rieß, J. Kormann, Dr. P. Kremer, Prof. N. Bleese. Foto: Andreas Rieß

 

patientenuni

 

patientenuni

 

herzbruecke